Eleven Therapeutics
Eleven Therapeutics is a biotechnology company developing RNA therapeutics using synthetic chemistry and artificial intelligence.
Sponsor licence details
Sourced from the UK Home Office register of licensed sponsors.
About Eleven Therapeutics
Eleven Therapeutics is a research and biotechnology company focused on transforming RNAi drug development into a programmable process. The company utilises massively parallel combinatorial chemistry alongside artificial intelligence algorithms to map chemical structures and optimise RNA molecules.
Its proprietary platform is designed to analyse the structure-activity relationship of molecules. This process allows the company to systematically optimise the safety, efficiency, and duration of effect for its pipeline of mRNA therapeutics.
Open roles
2 live positions matched to this sponsor licence.